In vitro Adhesion and Proliferation of MG63 Osteoblast-Like Cell Line on Bio-Oss and Bone+B Xenografts

Technical Summary: In Vitro Adhesion and Proliferation of MG63 Osteoblast-Like Cells on Bio-Oss and Bone+B Xenografts

Problem Statement
Bone regeneration following resorption from tooth extraction, periodontal disease, or trauma remains a significant challenge in dentistry. While Guided Bone Regeneration (GBR) techniques utilize various graft materials—autografts, allografts, alloplasts, and xenografts—each possesses distinct limitations. Autografts are the gold standard but suffer from donor site morbidity and limited availability; allografts carry risks of disease transmission and immune rejection; and alloplasts lack osteoinductive properties. Consequently, xenografts, particularly bovine-derived bone, have emerged as a preferred alternative due to their osteoconductive properties and ability to serve as a scaffold for new bone formation. However, the biological interaction between specific xenograft materials and osteoblasts is critical for successful GBR. While the surface topography and porosity of xenografts are known to influence cell retention and proliferation, direct comparative data on the biological behavior of MG63 osteoblast-like cells on Bio-Oss versus the Bone+B xenograft was lacking prior to this study.

Methodology
This was an in vitro experimental study designed to evaluate the adhesion and proliferation of the MG63 osteoblast-like cell line on two specific xenografts: Bio-Oss (Geistlich Pharma, Switzerland) and Bone+B (NavaTeb Pars, Iran).

• Experimental Design: The study utilized a 24-well plate system. To prevent cells from adhering to the plastic bottom of the wells, all wells (except the control) were coated with 0.1% agar.
• Sample Preparation: Each experimental well received 100 mg of xenograft particles. MG63 cells (second passage) were cultured in Dulbecco's modified Eagle's medium supplemented with 11% fetal bovine serum.
• Cell Seeding: A density of 5 × 10⁴ cells/well was introduced to the xenograft particles.
• Time Points:
  • Adhesion: Evaluated after 24 hours.
  • Proliferation: Evaluated after 3 and 5 days.
• Assessment Techniques:
  • Cell Adhesion: Assessed via the Methyl Thiazolyl Tetrazolium (MTT) assay after 24 hours. Unattached cells were removed by rinsing with PBS.
  • Cell Proliferation: Assessed via the MTT assay at days 3 and 5. Optical density (OD) was measured at 450 nm using an ELISA reader, with a standard curve used to quantify cell numbers.
  • Morphology: Scanning Electron Microscopy (SEM) was performed at 24 hours (x3000 and x6000 magnification) to visualize cell adhesion to the graft surfaces.
• Statistical Analysis: Data were analyzed using non-parametric tests (Kruskal-Wallis, Mann-Whitney, and Wilcoxon) with a significance level of alpha = 0.05.

Key Results

• Cell Adhesion (24 Hours):
  • The control group (culture medium without powder) exhibited the highest cell adhesion.
  • Adhesion in the control group was significantly higher than in the Bone+B group (P = 0.03) but not significantly different from the Bio-Oss group (P = 0.48).
  • There was no statistically significant difference in adhesion between the Bio-Oss and Bone+B groups (P = 0.27), although Bio-Oss showed a slightly higher mean adhesion value.
  • SEM micrographs confirmed cell attachment to both xenograft materials.
• Cell Proliferation (Days 3 and 5):
  • Both xenograft groups (Bio-Oss and Bone+B) demonstrated significantly higher cell proliferation compared to the control group at both time points (P < 0.05).
  • Bio-Oss Superiority: The Bio-Oss group showed significantly higher cell proliferation compared to the Bone+B group at both day 3 (P = 0.03) and day 5 (P = 0.04).
  • Within each xenograft group, proliferation increased from day 3 to day 5, though this temporal increase was not statistically significant.

Key Contributions
This study provides a direct comparative analysis of two commercially available xenografts (Bio-Oss and Bone+B) regarding their interaction with MG63 osteoblast-like cells. The primary contribution is the demonstration that while both materials support cell adhesion and proliferation better than a cell-free control environment, they are not biologically equivalent. Specifically, the study identifies that Bio-Oss promotes significantly higher osteoblast proliferation compared to Bone+B, despite both materials showing comparable adhesion capabilities.

Significance and Claims
The authors claim that this in vitro study highlights that different xenografts exert distinct effects on the biological behavior of osteoblast-like cells. The findings suggest that while both Bio-Oss and Bone+B are biocompatible and support cell growth, the specific material composition or surface properties of Bio-Oss may offer a proliferative advantage.

The paper maintains a modest scope regarding its conclusions:

1. Comparability: It establishes that adhesion is comparable between the two xenografts.
2. Differentiation: It distinguishes the materials based on proliferation rates, favoring Bio-Oss.
3. Limitations: The authors explicitly note that the study is in vitro and cannot perfectly simulate complex in vivo cell interactions. They acknowledge that only one cell type (MG63) and a single time point for adhesion were assessed. Consequently, the authors state that results should be generalized to the clinical setting with caution and call for future studies involving other cell types, longer timeframes, and investigations into cell differentiation and mineralization.